Oslo University Hospital, Oslo, Norway
My main scientific interest has always been to understand cancer biology and to contribute to improving the treatment of this disease.
My scientific background is broad, having experience in working with different model systems and techniques. I obtained a Ph.D. degree in Biology, working with the budding yeast Saccharomyces cerevisiae. I explored the effect of the deregulation of CDK activity during the G1 phase of the cell cycle on genomic stability, mimicking what happens at the beginning of cancer development.
During my postdoctoral period, I’ve focused on cancer biology, from basic research, understanding the molecular mechanisms behind drug sensitivity, to more applied and translational aspects such as developing a personalized medicine platform for leukemia and melanoma patients. I use high-throughput methods to screen the effect of drug libraries (both as single compounds and in combination, to study drug synergies) on primary cells and cancer-derived cell lines.
Disclosure information not submitted.
Wednesday, February 9, 2022
10:30 AM – 11:00 AM